Literature DB >> 26568189

Therapy: New data do not support use of abatacept in diabetic nephropathy.

Gerald B Appel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26568189     DOI： 10.1038/nrneph.2015.178

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.

Authors:  Elena Gagliardini; Rubina Novelli; Daniela Corna; Carlamaria Zoja; Barbara Ruggiero; Ariela Benigni; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

2.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Chih-Chuan Yu; Alessia Fornoni; Astrid Weins; Samy Hakroush; Dony Maiguel; Junichiro Sageshima; Linda Chen; Gaetano Ciancio; Mohd Hafeez Faridi; Daniel Behr; Kirk N Campbell; Jer-Ming Chang; Hung-Chun Chen; Jun Oh; Christian Faul; M Amin Arnaout; Paolo Fiorina; Vineet Gupta; Anna Greka; George W Burke; Peter Mundel
Journal:  N Engl J Med       Date:  2013-11-08       Impact factor: 91.245

3.  Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

Authors:  Dick de Zeeuw; Tadao Akizawa; Paul Audhya; George L Bakris; Melanie Chin; Heidi Christ-Schmidt; Angie Goldsberry; Mark Houser; Melissa Krauth; Hiddo J Lambers Heerspink; John J McMurray; Colin J Meyer; Hans-Henrik Parving; Giuseppe Remuzzi; Robert D Toto; Nosratola D Vaziri; Christoph Wanner; Janet Wittes; Danielle Wrolstad; Glenn M Chertow
Journal:  N Engl J Med       Date:  2013-11-09       Impact factor: 91.245

4.  Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis.

Authors:  Eduardo H Garin; Wei Mu; John M Arthur; Christopher J Rivard; Carlos E Araya; Michiko Shimada; Richard J Johnson
Journal:  Kidney Int       Date:  2010-05-19       Impact factor: 10.612

5.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Ariela Benigni; Elena Gagliardini; Giuseppe Remuzzi
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

6.  Abatacept in B7-1-positive proteinuric kidney disease.

Authors:  Nada Alachkar; Naima Carter-Monroe; Jochen Reiser
Journal:  N Engl J Med       Date:  2014-03-27       Impact factor: 91.245

7.  Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.

Authors: 
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

8.  Sulodexide fails to demonstrate renoprotection in overt type 2 diabetic nephropathy.

Authors:  David K Packham; Rory Wolfe; Anne T Reutens; Tomas Berl; Hiddo Lambers Heerspink; Richard Rohde; Sara Ivory; Julia Lewis; Itamar Raz; Thomas B Wiegmann; Juliana C N Chan; Dick de Zeeuw; Edmund J Lewis; Robert C Atkins
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

9.  Role of podocyte B7-1 in diabetic nephropathy.

Authors:  Paolo Fiorina; Andrea Vergani; Roberto Bassi; Monika A Niewczas; Mehmet M Altintas; Marcus G Pezzolesi; Francesca D'Addio; Melissa Chin; Sara Tezza; Moufida Ben Nasr; Deborah Mattinzoli; Masami Ikehata; Domenico Corradi; Valerie Schumacher; Lisa Buvall; Chih-Chuan Yu; Jer-Ming Chang; Stefano La Rosa; Giovanna Finzi; Anna Solini; Flavio Vincenti; Maria Pia Rastaldi; Jochen Reiser; Andrzej S Krolewski; Peter H Mundel; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

10.  Induction of B7-1 in podocytes is associated with nephrotic syndrome.

Authors:  Jochen Reiser; Gero von Gersdorff; Martin Loos; Jun Oh; Katsuhiko Asanuma; Laura Giardino; Maria Pia Rastaldi; Novella Calvaresi; Haruko Watanabe; Karin Schwarz; Christian Faul; Matthias Kretzler; Anne Davidson; Hikaru Sugimoto; Raghu Kalluri; Arlene H Sharpe; Jordan A Kreidberg; Peter Mundel
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808
  10 in total
  1 in total

Review 1.  How immunosuppressive drugs may directly target podocytes in glomerular diseases.

Authors:  Maurizio Salvadori; Aris Tsalouchos
Journal:  Pediatr Nephrol       Date:  2021-07-09       Impact factor: 3.651
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.